Current treatment approach to non-clear cell renal carcinoma

by I. V. Tsimafeyeu
Published 2015-12-01

Five-year overall survival of metastatic renal cell carcinoma patients treated with everolimus after progression on bevacizumab: a prospective multicenter study CRAD001LRU02T

by S. Z. Safina, S. A. Varlamov, A. V. Snegovoy, I. S. Varlamov, L. I. Gurina, L. V. Manzuk, I. V. Tsimafeyeu
Published 2018-01-01

Expression of growth factors and tyrosine kinase receptors in the primary tumor and tumor thrombus cells in patients with renal cell carcinoma

by M. I. Volkova, A. S. Olshanskaya, I. V. Tsimafeyeu, N. L. Vashakmadze, Yu. A. Khochenkova, E. Sh. Solomko, S. A. Ashuba, D. A. Khochenkov, V. B. Matveev
Published 2020-04-01